We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
Hot Features
Premium
RNS Number:2771O
Celsis International PLC
30 June 2005
Celsis International plc
Celsis International plc (the "Company"), the microbial contamination and
analytical services group, today announces:
Copies of the Company's Annual Report and Accounts for the year ended 31 March
2005 have been dispatched to shareholders and submitted to the UK Listing
Authority, and will shortly be available for inspection at the Document Viewing
Facility, which is situated at:
Financial Services Authority, 25 The North Colonnade, Canary Wharf, London E14
5HS
Tel: 020 7066 1000
Enquiries:
Celsis International plc
Tel: 01638 600 151
Christian Madrolle, Finance Director & Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSBBGDLBSXGGUG
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
